These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29330173)

  • 1. Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes.
    Ballif M; Zürcher K; Reid SE; Boulle A; Fox MP; Prozesky HW; Chimbetete C; Zwahlen M; Egger M; Fenner L;
    BMJ Open; 2018 Jan; 8(1):e017405. PubMed ID: 29330173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
    Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.
    Zürcher K; Ballif M; Kiertiburanakul S; Chenal H; Yotebieng M; Grinsztejn B; Michael D; Sterling TR; Ngonyani KM; Mandalakas AM; Egger M; Pettit AC; Fenner L;
    J Int AIDS Soc; 2019 Sep; 22(9):e25392. PubMed ID: 31507083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
    Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
    Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
    Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
    Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studies.
    Trickey A; Johnson LF; Fung F; Bonifacio R; Iwuji C; Biraro S; Bosomprah S; Chirimuta L; Euvrard J; Fatti G; Fox MP; Von Groote P; Gumulira J; Howard G; Jennings L; Kiragga A; Muula G; Tanser F; Wagener T; Low A; Vickerman P
    BMC Infect Dis; 2023 Dec; 23(1):889. PubMed ID: 38114912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort.
    Arpagaus A; Franzeck FC; Sikalengo G; Ndege R; Mnzava D; Rohacek M; Hella J; Reither K; Battegay M; Glass TR; Paris DH; Bani F; Rajab ON; Weisser M;
    PLoS One; 2020; 15(3):e0229875. PubMed ID: 32130279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
    AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
    Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era.
    Álvaro-Meca A; Díaz A; de Miguel Díez J; Resino R; Resino S
    PLoS One; 2016; 11(11):e0165944. PubMed ID: 27812194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
    Brennan AT; Bonawitz R; Schnippel K; Berhanu R; Maskew M; Long L; Bassett J; Sanne I; Fox MP
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1040-5. PubMed ID: 27393537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
    Peltzer K; Ramlagan S; Khan MS; Gaede B
    SAHARA J; 2011; 8(4):179-86. PubMed ID: 23236959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
    Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends, seasonality and forecasts of pulmonary tuberculosis in Portugal.
    Bras AL; Gomes D; Filipe PA; de Sousa B; Nunes C
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1202-10. PubMed ID: 25216834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.